Sisram Medical Ltd. announced that t Mr. Chun LI and Ms. Yu HU have tendered their resignation from the positions of non-executive directors of the company with effect from 19 March 2018 due to their other work commitments. The Board also announced that, with effect from 19 March 2018, Mr. Jianping HUA has been appointed as an executive director of the company and Ms. Yang YANG has been appointed as a non-executive director of the company. Mr. Hua has been the Chief Financial Officer and Secretary to the board of directors of the Company since February 2014. He is responsible for the financial operation, board administrative matters and financing and investment activities of the Group. Mr. Hua has more than 10 years professional financial and investment experience. He held a number of positions comprising vice director of financial audit, director of financial audit and deputy general manager of the finance department of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. Ms. Yang has been the senior manager of Sincere Holding Group Co. Ltd. in charge of matters relating to employees' performance and development and the human resources manager of Sino-Singapore Interconnection Investment Fund Management Co. Ltd. since March 2016. Mr. Hua has entered into a letter of appointment with the Company for a period commencing from 19 March 2018 and ending on 30 August 2020 in accordance with the Articles of Association of the Company. Ms. Yang has entered into a letter of appointment with the Company for a period commencing from 19 March 2018 and ending on 30 August 2020 in accordance with the Articles of Association of the company. The Board also announced that Mr. Ronen LAZAROVICH has tendered his resignation from the position of Chief Operating Officer of the Company with effect from 31 March 2018 due to his other work commitments. Mr. Lazarovich has confirmed that he has no disagreement with the Board and there are no matters relating to his resignation that need to be brought to the Shareholders. The Board also announced that Mr. Ran EZIONI will assume the position of Chief Operating Officer of the Company with effect from 1 April 2018. Mr. Ezioni brings over 22 years of multi-dimensional experience in the fields of global operations, supply chain management, information technology, outsourcing and service and maintenance in various industries, including the medical aesthetic industry. Prior to joining the Company, Mr. Ezioni served as a vice president of global supply chain, purchasing and information technology at Arkal Automotive, a global developer and worldwide manufacturer of solutions for the global automotive industry. Mr. Ezioni holds a bachelor of science degree in Industrial Engineering from the Technion, the Israeli Institute of Technology, with honors, and is Certified Six Sigma Black Belt (CSSBB) by the American Society for Quality. The Board also announced the appointment of Mr. Avraham FARBSTEIN as Chief Strategy Officer of the Company with effect from 19 March 2018. Mr. Farbstein has been serving as chief executive officer of the Group's North America operations since March 2013, successfully leading major business development and business expansion ventures in this strategic market. Mr. Farbstein has more than 35 years of experience in the medical and aesthetic devices industry beginning with his involvement in research and development of one of the first lasers introduced into the surgical devices field. Mr. Farbstein holds a bachelor of science degree in electric engineering from Tel Aviv University in Israel.